• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yosida Ryohei  吉田 遼平

ORCIDConnect your ORCID iD *help
… Alternative Names

Yoshida Ryohei  吉田 遼平

YOSHIDA Ryouhei  吉田 遼平

Less
Researcher Number 40792883
Other IDs
Affiliation (Current) 2025: 医療法人社団慶友会吉田病院(臨床研究センター), がん生物研究部, 所長
2025: 旭川医科大学, 医学部, 客員助教
Affiliation (based on the past Project Information) *help 2023 – 2024: 旭川医科大学, 医学部, 客員助教
2022: 旭川医科大学, 医学部, 特任助教
2019: 旭川医科大学, 大学病院, 助教
2018 – 2019: 旭川医科大学, 大学病院, 特任助教
2017: 旭川医科大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
Basic Section 53030:Respiratory medicine-related / Basic Section 50010:Tumor biology-related / Basic Section 50020:Tumor diagnostics and therapeutics-related
Except Principal Investigator
Respiratory organ internal medicine
Keywords
Principal Investigator
薬剤耐性 / 免疫療法 / EGFR / 非小細胞肺がん / 免疫チェックポイント阻害薬 / DPP4 / CD73 / EGFR遺伝子変異 / アデノシン経路 / EGFR肺がん … More / EGFR肺癌 / ドロップレットデジタルPCR / 分子標的薬 / トリプルネガティブ乳がん / 肺がん / 変異 / 耐性変異 / ドライバー遺伝子 / 液体生検 … More
Except Principal Investigator
T790M / KRAS / ALK / EGFR / ALK G1202R / EGFR C797S / EGFR T790M / 肺癌 / デジタルPCR / 液体生検 Less
  • Research Projects

    (4 results)
  • Research Products

    (2 results)
  • Co-Researchers

    (4 People)
  •  EGFR肺がんの新規免疫標的分子の発見と機能解明Principal Investigator

    • Principal Investigator
      吉田 遼平
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Asahikawa Medical College
  •  Development of Immunotherapy Utilizing the Adenosine Pathway in EGFR-Mutant Lung CancerPrincipal Investigator

    • Principal Investigator
      Yoshida Ryohei
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Asahikawa Medical College
  •  Prediction of driver gene resistance mutations by liquid biopsyPrincipal Investigator

    • Principal Investigator
      Yoshida Ryohei
    • Project Period (FY)
      2018 – 2019
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Asahikawa Medical College
  •  Monitoring of Emerging Resistance of Lung Cancer using Liquid Biopsy

    • Principal Investigator
      TANNO Sachie
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Respiratory organ internal medicine
    • Research Institution
      Asahikawa Medical College

All 2017 2016

All Journal Article Presentation

  • [Journal Article] ALK阻害薬の耐性機序と次世代ALK阻害薬2017

    • Author(s)
      吉田遼平、 佐々木高明
    • Journal Title

      腫瘍内科

      Volume: 19/5 Pages: 526-531

    • Data Source
      KAKENHI-PROJECT-15K09239
  • [Presentation] 非小細胞肺癌を対象としたデジタルPCRによるliquid biopsy2016

    • Author(s)
      小野 裕介, 佐々木 高明, 吉田 遼平, 安藤 清宏, 大崎 能伸, 水上 裕輔
    • Organizer
      日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-15K09239
  • 1.  TANNO Sachie (80455724)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  水上 裕輔 (30400089)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 3.  小野 裕介 (40742648)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 4.  佐々木 高明 (70516997)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi